Regal Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.41M | Buy |
3,710
+324
| +10% | +$328K | 0.2% | 134 |
|
|
2025
Q4 | $3.64M | Buy |
3,386
+636
| +23% | +$608K | 0.22% | 120 |
|
|
2025
Q3 | $2.1M | Buy |
2,750
+249
| +10% | +$185K | 0.14% | 172 |
|
|
2025
Q2 | $1.95M | Buy |
2,501
+115
| +5% | +$89.4K | 0.15% | 155 |
|
|
2025
Q1 | $1.97M | Sell |
2,386
-852
| -26% | -$709K | 0.16% | 150 |
|
|
2024
Q4 | $2.5M | Sell |
3,238
-1,350
| -29% | -$1.12M | 0.19% | 130 |
|
|
2024
Q3 | $4.06M | Sell |
4,588
-735
| -14% | -$661K | 0.28% | 107 |
|
|
2024
Q2 | $4.82M | Buy |
5,323
+16
| +0.3% | +$12.8K | 0.31% | 90 |
|
|
2024
Q1 | $4.13M | Buy |
5,307
+499
| +10% | +$355K | 0.28% | 103 |
|
|
2023
Q4 | $2.8M | Buy |
4,808
+1,405
| +41% | +$820K | 0.21% | 128 |
|
|
2023
Q3 | $1.83M | Buy |
3,403
+148
| +5% | +$76.3K | 0.15% | 156 |
|
|
2023
Q2 | $1.53M | Buy |
3,255
+473
| +17% | +$198K | 0.13% | 165 |
|
|
2023
Q1 | $956K | Sell |
2,782
-450
| -14% | -$152K | 0.08% | 201 |
|
|
2022
Q4 | $1.18M | Sell |
3,232
-271
| -8% | -$96.1K | 0.11% | 171 |
|
|
2022
Q3 | $1.13M | Buy |
3,503
+333
| +11% | +$106K | 0.12% | 166 |
|
|
2022
Q2 | $1.03M | Buy |
3,170
+642
| +25% | +$193K | 0.11% | 176 |
|
|
2022
Q1 | $723K | Buy |
2,528
+9
| +0.4% | +$2.32K | 0.07% | 257 |
|
|
2021
Q4 | $696K | Buy |
2,519
+136
| +6% | +$34.5K | 0.06% | 290 |
|
|
2021
Q3 | $551K | Buy |
2,383
+37
| +2% | +$9.13K | 0.05% | 319 |
|
|
2021
Q2 | $538K | Buy |
+2,346
| New | +$471K | 0.05% | 319 |
|
|
2021
Q1 | – | Sell |
-1,975
| Closed | -$333K | – | 254 |
|
|
2020
Q4 | $333K | Buy |
+1,975
| New | +$295K | 0.04% | 341 |
|
|
2020
Q3 | – | Sell |
-4,129
| Closed | -$678K | – | 149 |
|
|
2020
Q2 | $678K | Buy |
+4,129
| New | +$634K | 0.12% | 155 |
|
|
2019
Q2 | – | Sell |
-1,580
| Closed | -$205K | – | 347 |
|
|
2019
Q1 | $205K | Sell |
1,580
-826
| -34% | -$100K | 0.04% | 290 |
|
|
2018
Q4 | $278K | Sell |
2,406
-678
| -22% | -$75.7K | 0.06% | 261 |
|
|
2018
Q3 | $331K | Buy |
+3,084
| New | +$308K | 0.07% | 229 |
|
|
2018
Q2 | – | Sell |
-3,062
| Closed | -$237K | – | 288 |
|
|
2018
Q1 | $237K | Buy |
3,062
+408
| +15% | +$32.8K | 0.05% | 258 |
|
|
2017
Q4 | $224K | Sell |
2,654
-254
| -9% | -$21.6K | 0.05% | 258 |
|
|
2017
Q3 | $249K | Buy |
2,908
+273
| +10% | +$22.4K | 0.06% | 235 |
|
|
2017
Q2 | $217K | Buy |
+2,635
| New | +$215K | 0.05% | 242 |
|
|
2015
Q4 | – | Sell |
-369
| Closed | -$30K | – | 615 |
|
|
2015
Q3 | $30K | Buy |
369
+46
| +14% | +$3.88K | 0.01% | 493 |
|
|
2015
Q2 | $26K | Buy |
323
+50
| +18% | +$3.81K | 0.01% | 520 |
|
|
2015
Q1 | $20K | Buy |
273
+25
| +10% | +$1.78K | ﹤0.01% | 566 |
|
|
2014
Q4 | $17K | Hold |
248
| – | – | ﹤0.01% | 561 |
|
|
2014
Q3 | $16K | Sell |
248
-204
| -45% | -$12.9K | ﹤0.01% | 599 |
|
|
2014
Q2 | $28K | Buy |
452
+159
| +54% | +$9.49K | 0.01% | 487 |
|
|
2014
Q1 | $17K | Sell |
293
-387
| -57% | -$21.6K | 0.01% | 547 |
|
|
2013
Q4 | $35K | Sell |
680
-218
| -24% | -$10.9K | 0.02% | 347 |
|
|
2013
Q3 | $45K | Sell |
898
-83
| -8% | -$4.34K | 0.03% | 315 |
|
|
2013
Q2 | $48K | Buy |
+981
| New | +$53.4K | 0.03% | 296 |
|
Other funds holding LLY
VCM
VPM
Regal Investment Advisors's LLY Position: Q1 2026 in Review
Regal Investment Advisors increased its Eli Lilly (LLY) stake by 9.6% in Q1 2026, buying an estimated $328K and bringing the position to 3,710 shares worth $3.41M. The position accounts for 0.2% of the portfolio, ranked #134.
Regal Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 39 quarters since. The position peaked at $4.82M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Regal Investment Advisors held 3,710 shares of Eli Lilly worth $3.41M as of Q1 2026.
- Regal Investment Advisors bought 324 Eli Lilly shares in Q1 2026, an estimated $328K.
- Eli Lilly made up 0.2% of Regal Investment Advisors's portfolio in Q1 2026, its #134 holding.
- Regal Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 39 quarters since.
- Regal Investment Advisors's Eli Lilly position peaked at $4.82M in Q2 2024.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.